Infection and ImmunityMicrobiologyPeer-reviewed journal article
RodA Promotes Intestinal Colonization by Group B Streptococcus
Michelle J. VaziD, Sanjana Sankaran, Molly E. SharpiD, Emily Dembinski, Adam J. RatneriD
Abstract
BackgroundGroup B Streptococcus (GBS) intestinal colonization is critical for the pathogenesis of late-onset (LO) disease in infants. Using a murine model, we explore the role of rodA, which encodes a peptidoglycan polymerase RodA, belonging to the Shape, Elongation, Division, and Sporulation (SEDS) family that participates in peptidoglycan synthesis and maintenance of cell wall integrity. MethodsWe investigated the contribution of rodA to GBS gastrointestinal (GI) colonization using a wild-type strain (A909 WT) and an isogenic in-frame deletion mutant of rodA (A909{Delta}rodA). Morphological differences between the two strains were examined by transmission electron microscopy (TEM), and the contribution of rodA to GI colonization was assessed in a murine model through monocolonization and cocolonization experiments. We evaluated the growth of the mutant strain under intestinal physiological stress conditions and characterized its interactions with host epithelial cells in vitro. ResultsA909{Delta}rodA showed a unique chaining/aggregation phenotype compared to the A909 WT strain, with the presence of capsule confirmed via TEM and immunoblotting. In murine cocolonization experiments, A909 WT outcompeted A909{Delta}rodA; however, monocolonization experiments exhibited comparable colonization and bacterial burden across the GI tract. In vitro experiments revealed impaired growth in bile and an increase in adhesion to intestinal epithelial cells by the {Delta}rodA mutant. Conclusion(s)rodA plays a role in GBS intestinal colonization. Deletion of rodA increases sensitivity to gastrointestinal stressors in vitro and causes a pronounced defect in competition in vivo, suggesting that the presence of rodA increases the fitness of GBS in the gut.
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 1
- FWCI
- 6.48
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A murine model of adult gastrointestinal colonization by Group B Streptococcus
Joie Ling, Luke R. Joyce, … Andrew J. Hryckowian·Infection and ImmunityPeer-reviewed·Jan 30, 2026
- Macrophage renewal in the small intestine governs early-life control of streptococci
Zohreh Mansoori Moghadam, Mirjam Freudenhammer, … Philipp Henneke·bioRxiv·Feb 12, 2026
- Microbial Crosstalk in the Neonatal Gut: Candida albicans Impacts Group B Streptococcus Pathogenicity
April K. Lindon, Alexia N. Pearah, … Tara Marie Randis·bioRxiv·Oct 5, 2026
- Group B Streptococcus drives major transcriptomic changes in the colonic epithelium.
K. Dominguez, A. K. Lindon, … T. M. Randis·bioRxiv·Jan 24, 2023
- Akkermansia muciniphila Impacts Group B Streptococcus Vaginal Colonization
Stephanie M Marroquin, Shirli Cohen, … Kelly S. Doran·mBioPeer-reviewed·Apr 27, 2026
- Competitive advantage of hypervirulent Group B Streptococcus for neonatal colonization revealed by metagenomic analysis of gut microbiota
Anne‐Sophie Alvarez, Florian Plaza Oñate, … Asmaa Tazi·bioRxiv·Jun 19, 2026